Brief: Sosei Heptares Receives $10 Mln Milestone Payment In Discovery Collaboration With Abbvie Targeting Inflammatory Diseases
13/12/2022 06:35
Dec 13 (Reuters) - Sosei Group Corp 4565.T :
* SOSEI HEPTARES RECEIVES $10 MILLION MILESTONE PAYMENT IN
DISCOVERY COLLABORATION WITH ABBVIE TARGETING INFLAMMATORY
DISEASES
* SAYS HAS REACHED AN IMPORTANT RESEARCH AND DEVELOPMENT
MILESTONE
UNDER ITS DISCOVERY COLLABORATION WITH ABBVIE
* SOSEI GROUP - UNDER TERMS OF AGREEMENT, SOSEI HEPTARES IS
ELIGIBLE TO RECEIVE UP TO US$32 MILLION IN UPFRONT AND NEAR-TERM
MILESTONE PAYMENTS
* SOSEI GROUP -UNDER TERMS, CO TO GET POTENTIAL OPTION,
DEVELOPMENT, COMMERCIAL MILESTONES OF UP TO $377 MILLION, PLUS
ROYALTIES ON GLOBAL COMMERCIAL SALES
Source text for Eikon: ID:nGNX6bktlM
Further company coverage: 4565.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up